Hemogenyx Pharmaceuticals (UK) Insiders
| HEMO Stock | 364.50 2.00 0.55% |
Hemogenyx Pharmaceuticals employs about 17 people. The company is managed by 5 executives with a total tenure of roughly 40 years, averaging almost 8.0 years of service per executive, having 3.4 employees per reported executive. Breaking down Hemogenyx Pharmaceuticals' management performance can provide insight into the firm performance.
| Vladislav Sandler CEO CEO CoFounder |
Hemogenyx |
Hemogenyx Pharmaceuticals Management Team Effectiveness
The company has return on total asset (ROA) of (0.3779) % which means that it has lost $0.3779 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.5597) %, meaning that it generated substantial loss on money invested by shareholders. Hemogenyx Pharmaceuticals' management efficiency ratios could be used to measure how well Hemogenyx Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Hemogenyx Pharmaceuticals Workforce Comparison
Hemogenyx Pharmaceuticals PLC is one of the top stocks in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 184,474. Hemogenyx Pharmaceuticals adds roughly 17.0 in number of employees claiming only tiny portion of equities under Health Care industry.
Hemogenyx Pharmaceuticals Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Hemogenyx Pharmaceuticals Price Series Summation is a cross summation of Hemogenyx Pharmaceuticals price series and its benchmark/peer.
Hemogenyx Pharmaceuticals Notable Stakeholders
A Hemogenyx Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Hemogenyx Pharmaceuticals often face trade-offs trying to please all of them. Hemogenyx Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Hemogenyx Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Vladislav Sandler | CEO CoFounder | Profile | |
| Alexis JD | Independent Director | Profile | |
| Koen MD | Clinical Director | Profile | |
| Ben Harber | Company Secretary | Profile | |
| Andrew Wright | Financial Sec | Profile |
About Hemogenyx Pharmaceuticals Management Performance
The success or failure of an entity such as Hemogenyx Pharmaceuticals often depends on how effective the management is. Hemogenyx Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Hemogenyx management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Hemogenyx management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please note, the imprecision that can be found in Hemogenyx Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Hemogenyx Pharmaceuticals PLC. Check Hemogenyx Pharmaceuticals' Beneish M Score to see the likelihood of Hemogenyx Pharmaceuticals' management manipulating its earnings.
Hemogenyx Pharmaceuticals Workforce Analysis
Traditionally, organizations such as Hemogenyx Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Hemogenyx Pharmaceuticals within its industry.Hemogenyx Pharmaceuticals Manpower Efficiency
Return on Hemogenyx Pharmaceuticals Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 393.6K | |
| Net Loss Per Executive | 1.3M | |
| Working Capital Per Employee | 89.3K | |
| Working Capital Per Executive | 303.5K |
Additional Tools for Hemogenyx Stock Analysis
When running Hemogenyx Pharmaceuticals' price analysis, check to measure Hemogenyx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hemogenyx Pharmaceuticals is operating at the current time. Most of Hemogenyx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Hemogenyx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hemogenyx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Hemogenyx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.